Related Interviews

Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
October 20, 2024
Brozak, Steve

New Drug Trials Spur Continued Interest in Anti-Obesity Space
October 20, 2024
Phipps, Matt

Skip the Needles — Delivering Biologics in Oral Form
October 20, 2024
Vandermosten, John

Three Large-Cap Names with Strong Fundamental and ESG Stories
September 08, 2024
D’Amore, Samantha

Seeking Out Game Changers in Re-Emerging Biotech Sector
April 18, 2024
Bayko, Liisa

Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
April 18, 2024
Baum, Andrew

E-Commerce and Enterprise Software Positioned to Reaccelerate Growth
December 14, 2023
Armbruster, Chris

Spotlighting U.S. and Global Companies With Good Sustainability Profiles
July 05, 2023
Herman, R. Paul

International Equity Investing to Benefit from Potential Tailwinds
April 03, 2023
Flores, Jesse, Li, Haicheng, Lubchenco, David, Velarde, Nathaniel

Reimbursement May Be a Hurdle to Success for Med-Tech Companies
July 12, 2019
Marckx, Brian

Drug Pricing Power Moves from Pharmaceutical Companies to Pharmacy Benefit Managers
March 10, 2017
McGarry, Stephen

Looking for Biopharmaceuticals with Disruptive Innovation and Medicines Initiatives
August 12, 2016
Amusa, Gbola

Generating Higher Returns While Incurring Lower Risk
January 29, 2016
Fraise, George

Faster FDA Approvals and Paradigm-Shifting Breakthroughs Boost Pharma Stocks
March 28, 2014

Fundamental Value Investing Strategies
September 09, 2013

New Product Generation and an Easing Regulatory Environment in Biopharmaceuticals
August 05, 2013

Unit Trusts & Structured Investments In China - Scott Colyer - Advisors Asset Management, Inc.
January 24, 2011

Conservative & Flexible Active Portfolio Management - Sean Chaitman - Shelter Rock Management, Llc
September 20, 2010

Investing In Asian Mid-cap Growth Companies - Taizo Ishida - Matthews International Capital Management
August 09, 2010

Growth Stocks At Value Prices - Jeffrey R. Scharf - Scharf Investments Llc
February 08, 2010

The Keys To Successful Investing - Leon Loewenstine - Riverpoint Capital Management
January 11, 2010

Canadian Stocks With Growth & Value Potential - Neil Wickham - Wickham Investment Counsel Inc.
October 19, 2009

Post-crunch Trends In Biotechnology - Dr. Liana Moussatos - Wedbush Morgan Securities, Inc.
October 19, 2009

High Quality Growth Investing - Joseph T. Seminetta & Denise M. Seminetta - Premier Asset Management, Llc
October 05, 2009

SUCCESSFUL STRATEGIES IN A DIFFICULT ENVIRONMENT - MARTHA K. POMERANTZ - LOWRY HILL
November 24, 2008

SUSTAINABLE INVESTING WITH ESG ANALYSIS - CHRISTOPHER H. BROWN - PAX WORLD MANAGEMENT CORP.
November 17, 2008

OUTLOOK FOR GOLD MINING COMPANIES - PAUL O'BRIEN - RAYMOND JAMES LTD.
June 25, 2007

BARBARA COFFEY - KAUFMAN BROS., L.P.
September 25, 2006

Michael Cann - Washington Banking Company (wbco)
October 10, 2005

SOLID WASTE COMPANIES: MICHAEL HOFFMAN - FRIEDMAN, BILLINGS, RAMSEY GROUP INC
July 01, 2005

SEAN BOGDA - BRANDYWINE ASSET MANAGEMENT INC
May 23, 2005

VALERIE KAMPE - SIRACH CAPITAL MANAGEMENT
October 25, 2004

S.bablitch/m.bernstein - Cobalt Corporation (cbz)
September 13, 2002

Outlook For Biotechnology: John Rhodes - Deloitte & Touche
May 08, 2002

Canadian Biotechnology Stocks: Brian Bapty - Raymond James Ltd
May 06, 2002

Jeffrey Felman - Weber Fulton & Felman Investment Counsel Llc
March 25, 2002

Carl Colombo - Highmark Capital Management
October 02, 2000

Mark Hunter - Axon Group Plc (axo.l)
September 25, 2000

Lodging & Ski Companies: Bryan Maher - Credit Lyonnais Securities Usa
April 06, 2000

Hmos & Managed Care Companies : Robert J. Hoehn - Ing Baring Furman Selz
December 21, 1998

Uri David Landesman - J P Morgan Investment Mgmt
April 06, 1998